Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry

ObjectiveChronic hepatitis C virus infection is associated with a significant health burden. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The introduction of direct-acting antivirals (DAA) has led to an increase in sustained virologic response rates (SV

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Krüger, Kathrin (VerfasserIn) , Pathil-Warth, Anita (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 2019
In: European journal of gastroenterology & hepatology
Year: 2019, Jahrgang: 31, Heft: 2, Pages: 230-240
ISSN:1473-5687
DOI:10.1097/MEG.0000000000001283
Online-Zugang:Verlag, Volltext: https://doi.org/10.1097/MEG.0000000000001283
Volltext
Verfasserangaben:Kathrin Krüger, Christian Krauth, Siegbert Rossol, Stefan Mauss, Klaus Boeker, Tobias Müller, Hartwig Klinker, Anita Pathil, Renate Heyne, Jona Stahmeyer, and Collaborators DHC-R

MARC

LEADER 00000caa a2200000 c 4500
001 1677699833
003 DE-627
005 20230427002425.0
007 cr uuu---uuuuu
008 190925s2019 xx |||||o 00| ||eng c
024 7 |a 10.1097/MEG.0000000000001283  |2 doi 
035 |a (DE-627)1677699833 
035 |a (DE-599)KXP1677699833 
035 |a (OCoLC)1341244234 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Krüger, Kathrin  |d 1976-  |e VerfasserIn  |0 (DE-588)129677809  |0 (DE-627)477117201  |0 (DE-576)297781863  |4 aut 
245 1 0 |a Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals  |b results from the German Hepatitis C-Registry  |c Kathrin Krüger, Christian Krauth, Siegbert Rossol, Stefan Mauss, Klaus Boeker, Tobias Müller, Hartwig Klinker, Anita Pathil, Renate Heyne, Jona Stahmeyer, and Collaborators DHC-R 
264 1 |c February 2019 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.11.2019 
520 |a ObjectiveChronic hepatitis C virus infection is associated with a significant health burden. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The introduction of direct-acting antivirals (DAA) has led to an increase in sustained virologic response rates (SV 
700 1 |a Pathil-Warth, Anita  |d 1981-  |e VerfasserIn  |0 (DE-588)132644304  |0 (DE-627)524715890  |0 (DE-576)260118915  |4 aut 
773 0 8 |i Enthalten in  |t European journal of gastroenterology & hepatology  |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1989  |g 31(2019), 2, Seite 230-240  |h Online-Ressource  |w (DE-627)324743343  |w (DE-600)2030291-5  |w (DE-576)094835683  |x 1473-5687  |7 nnas  |a Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals results from the German Hepatitis C-Registry 
773 1 8 |g volume:31  |g year:2019  |g number:2  |g pages:230-240  |g extent:11  |a Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals results from the German Hepatitis C-Registry 
856 4 0 |u https://doi.org/10.1097/MEG.0000000000001283  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190925 
993 |a Article 
994 |a 2019 
998 |g 132644304  |a Pathil-Warth, Anita  |m 132644304:Pathil-Warth, Anita  |d 910000  |d 910100  |e 910000PP132644304  |e 910100PP132644304  |k 0/910000/  |k 1/910000/910100/  |p 8 
999 |a KXP-PPN1677699833  |e 3517880574 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"February 2019"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"pubHistory":["1.1989 -"],"part":{"volume":"31","extent":"11","pages":"230-240","year":"2019","issue":"2","text":"31(2019), 2, Seite 230-240"},"language":["eng"],"title":[{"title_sort":"European journal of gastroenterology & hepatology","subtitle":"official journal of the European Association for Gastroenterology and Endoscopy","title":"European journal of gastroenterology & hepatology"}],"recId":"324743343","note":["Gesehen am 20.05.14"],"origin":[{"publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]","dateIssuedKey":"1989","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1989-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals results from the German Hepatitis C-RegistryEuropean journal of gastroenterology & hepatology","id":{"zdb":["2030291-5"],"eki":["324743343"],"issn":["1473-5687"]},"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"eki":["1677699833"],"doi":["10.1097/MEG.0000000000001283"]},"language":["eng"],"title":[{"title":"Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals","subtitle":"results from the German Hepatitis C-Registry","title_sort":"Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals"}],"recId":"1677699833","note":["Gesehen am 29.11.2019"],"name":{"displayForm":["Kathrin Krüger, Christian Krauth, Siegbert Rossol, Stefan Mauss, Klaus Boeker, Tobias Müller, Hartwig Klinker, Anita Pathil, Renate Heyne, Jona Stahmeyer, and Collaborators DHC-R"]},"person":[{"roleDisplay":"VerfasserIn","role":"aut","family":"Krüger","given":"Kathrin","display":"Krüger, Kathrin"},{"family":"Pathil-Warth","given":"Anita","display":"Pathil-Warth, Anita","role":"aut","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"11 S."}]} 
SRT |a KRUEGERKATOUTCOMESAN2019